A Systematic Review of Surgical Characteristics and Adverse Events of an Active, Transcutaneous Bone Conduction Device

被引:0
|
作者
Jukic, Alma [1 ]
Munhall, Christopher C. [2 ]
Stevens, Shawn M. [3 ]
机构
[1] Univ Arizona, Coll Med Phoenix, Phoenix, AZ USA
[2] Med Univ South Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC USA
[3] Barrow Neurol Inst, Dept Otolaryngol & Skull Base Surg, 2910 N 3rd Ave, Phoenix, AZ 85013 USA
来源
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY | 2024年 / 133卷 / 11期
关键词
active transcutaneous hearing device; bone conduction implant; hearing loss; conductive hearing loss; Osia; bone-anchored hearing aid; CLINICAL-PERFORMANCE; IMPLANT; OUTCOMES; BAHA;
D O I
10.1177/00034894241283269
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: A new, active transcutaneous bone conduction device (BCD) was FDA-approved in 2019 in the USA. This systematic review sought to evaluate early outcomes associated with Osia implantation. Methods: A systematic review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Four databases were reviewed: PubMed, Scopus, Cochrane CENTRAL, and CINAHL. Studies were included if they described audiometric, surgical characteristics/complications, or adverse events associated with the Osia BCD. Exclusion criteria: non-English language studies, animal investigations, reviews/meta-analyses, case reports, database studies. Results: Eighteen studies with 336 patients were included. Mean age at implantation was 37.9 years. About 79.5% of patients had MHL/CHL and 19.5% had SSD/SHL. Mean operative time was 71.6 minutes. Mean PTA gain from unaided conditions was 35.4 dB. Mean functional gain at high frequency (6 kHz and above) from aided conditions was 16.1 dB. Mean improvement in speech recognition thresholds was 19.1 dB from unaided conditions. Adverse events (all types) were reported in 20.1% of cases. Across all studies, the postoperative infection rate was 5%. About 2% of patients reported magnet retention issues. About 1.65% of cases were complicated by hematomas. Conclusions: Under systematic literature review, the Osia BCD has been associated with low complication rates, relatively short operative times, and good audiometric and speech outcomes, notably high frequency gain >6 kHz. More advanced audiometric outcome reporting remains limited and audiometric data and patient reported outcome measures were reported heterogeneously.
引用
收藏
页码:956 / 966
页数:11
相关论文
共 50 条
  • [31] Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant
    Sprinzl, Georg
    Toner, Joseph
    Koitschev, Assen
    Berger, Nadine
    Keintzel, Thomas
    Rasse, Thomas
    Baumgartner, Wolf-Dieter
    Honeder, Clemens
    Magele, Astrid
    Plontke, Stefan
    Goetze, Gerrit
    Schmutzhard, Joachim
    Zelger, Philipp
    Corkill, Stephanie
    Lenarz, Thomas
    Salcher, Rolf
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2023, 280 (04) : 1565 - 1579
  • [32] Comparative outcomes of active and passive hearing devices by transcutaneous bone conduction
    Emilio Zernotti, Mario
    Fernanda Di Gregorio, Maria
    Galeazzi, Pablo
    Tabernero, Paola
    ACTA OTO-LARYNGOLOGICA, 2016, 136 (06) : 556 - 558
  • [33] The bonebridge as a transcutaneous bone conduction hearing system: preliminary surgical and audiological results in children and adolescents
    Hassepass, Frederike
    Bulla, Stefan
    Aschendorff, Antje
    Maier, Wolfgang
    Traser, Louisa
    Steinmetz, Christian
    Wesarg, Thomas
    Arndt, Susan
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2015, 272 (09) : 2235 - 2241
  • [34] Transcutaneous bone-conduction hearing device: audiological and surgical aspects in a first series of patients with mixed hearing loss
    Barbara, Maurizio
    Perotti, Marco
    Gioia, Barbara
    Volpini, Luigi
    Monini, Simonetta
    ACTA OTO-LARYNGOLOGICA, 2013, 133 (10) : 1058 - 1064
  • [35] Transcutaneous bone conduction implant with self-drilling screws A new method for fixation of an active transcutaneous bone conduction implant. German version
    Koitschev, Assen
    Neudert, Marcus
    Lenarz, Thomas
    HNO, 2024, 72 (08) : 554 - 560
  • [36] First United Kingdom experience of the novel Osia active transcutaneous piezoelectric bone conduction implant
    Lau, Kimberley
    Scotta, Gianluca
    Wright, Kay
    Proctor, Vicki
    Greenwood, Larissa
    Dawoud, Moustafa
    Ray, Jaydip
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (11) : 2995 - 3002
  • [37] Systematic and audiological indication criteria for bone conduction devices and active middle ear implants
    Rahne, Torsten
    Plontke, Stefan K.
    HEARING RESEARCH, 2022, 421
  • [38] Surgical and audiometric outcomes of active osseointegrated bone-conduction hearing device (CochlearTM Osia® 2 system) placement from a tertiary paediatric centre
    Mozaffari, Mona
    Guderley, Nicola
    Wong, Anita
    Konstantinidou, Sevasti
    Amin, Nikul
    Nash, Robert
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2025, 190
  • [39] Surgical Outcomes of Modified Technique for Transcutaneous Bone Conduction Hearing Aid Implantation
    Hicks, Kayla B.
    Brown, Kevin D.
    Selleck, A. Morgan
    Dedmon, Matthew M.
    Thompson, Nicholas J.
    LARYNGOSCOPE, 2024, 134 (05): : 2401 - 2404
  • [40] New Transcutaneous Bone Conduction Hearing Implant System: Surgical and Audiological Outcomes
    Swami, Himanshu
    Anand, Viswanathan
    Bhat, Sweekritha N.
    INDIAN JOURNAL OF OTOLOGY, 2018, 24 (04) : 252 - 256